Brief: Cyxone's Four Patent Applications Pertaining To Its Drug Candidate Rabeximod Published
Dec 17 (Reuters) - Cyxone AB CYXO.ST :
* CYXONE REPORTS PUBLICATION OF FOUR PATENT APPLICATIONS
PERTAINING TO ITS DRUG CANDIDATE RABEXIMOD
* FOUR PATENT APPLICATIONS PERTAINING TO ITS DRUG CANDIDATE
RABEXIMOD HAVE BEEN PUBLISHED BY PERCENT AUTHORITY (WIPO)
* IF APPROVED, THESE PATENTS HAVE POTENTIAL TO PROLONG
MARKET
EXCLUSIVITY OF RABEXIMOD UNTIL 2041.
Source text for Eikon: ID:nWkr1m07mQ
Further company coverage: CYXO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))